Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

BIOQUAL Inc (AKA: Diagnon Corporation)
Profile last edited on: 10/26/16      CAGE: 1DHW6      UEI: CK9LGQ7EBNN8

Business Identifier: medical research firm
Year Founded
1981
First Award
1983
Latest Award
2002
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

9600 Medical Center Drive
Rockville, MD 20850
   (301) 251-2801
   mof@bioqual.com
   www.bioqual.com
Location: Multiple
Congr. District: 08
County: Montgomery

Public Profile

BIOQUAL, Inc. (OTC: BIOQ) develops, produces and sells diagnostic test kits incorporating monoclonal antibodies to diagnose certain anemias, infections, and parasitic diseases. The principal activity of the Company is to conduct research on immunological, reproductive and transgenic studies and services, behavioral and neurological testing, digestive diseases and drug delivery. The company operates through five divisions: division of laboratory animal sciences, division of reproductive endocrinology and toxicology, division of neurobiology and behavior, division of primate biology and medicine and division of bioresearch. The company went public in June of 2002 on the OTC.

Extent of SBIR involvement

User Avatar
Phase I Awards
9
Phase II Awards
3
Conversion Rate
33.33%
Phase I Dollars
$691,453
Phase II Dollars
$1,791,991
Total Awarded
$2,483,444

Synopsis: Awardee Business Condition

Employee Range
150-249
Revenue Range
15M-20M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
OTC : BIOQ.PK
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2002 2 NIH $838,000
Project Title: Comparative DNA Sequence Variation in Alzheimer Genes
2000 1 NIH $98,711
Project Title: The Hyrax As A Model For Facial Biomechanics And Growth
1999 2 NIH $847,060
Project Title: Comparative Neurobiology Of Aging Resource
1997 1 NIH $99,673
Project Title: Identification Of H Pylori Protective Antigens
1997 1 NIH $100,000
Project Title: Nonhuman Primate Model For Helicobacter Pylori Infection

Key People / Management

  Mark G Lewis -- President / Chief Executive Officer

  Hanne Andersen -- Director of Research

  Joseph K Chen

  John J Ely

  Joseph M Erwin -- Vice President

  Mitch Franklin -- Vice President of Operations

  Nancy A Madden -- Vice President of Administration Operations Biosafety Officer / Responsible Offi

  David A Newcomer -- Chief Financial Officer

  Chander P Sarma -- Vice President of Facility Operations Director of Information Technology

  Marisa C St Claire -- Vice President

  Anthony R Welch

Company News

Feb 27 2014
BIOQUAL, Inc., Announces Completion of the Purchase of ABL's In-Vivo Animal Model Services Related Assets by BIOQUAL and Entry into Strategic Teaming Agreement.